Viewing Study NCT06534502

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-25 @ 3:46 AM
Ignite Modification Date: 2026-02-21 @ 8:46 AM
Study NCT ID: NCT06534502
Status: NOT_YET_RECRUITING
Last Update Posted: 2025-09-04
First Post: 2024-07-30
Is NOT Gene Therapy: True
Has Adverse Events: False
Brief Title: Study of the Pharmacokinetics, Safety, and Tolerability of ZONISADE in Children 1 Month to 17 Years of Age With Partial-onset Seizures
Sponsor: Azurity Pharmaceuticals
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Seizures View
None Seizures, Focal View
None Seizure, Partial Onset View
None Seizure Disorder, Partial View
None Seizure, Partial View
None Epilepsies, Partial View
None Epilepsy View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Partial-onset (focal) seizures View
None Pediatrics View
None ZONISADE View
None Zonisamide View